Telecom Healthcare Sector

NeuroScientific Biopharmaceuticals

Market Cap: AU$7.7m

Engages in the research and development of novel peptide-based pharmaceutical products.

BioElectronics

Market Cap: US$4.9m

An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.

Core One Labs

Market Cap: CA$6.8m

Operates as a psychedelic research and development company.

Dogecoin Cash

Market Cap: US$4.9m

Through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.

DATATRAK International

Market Cap: US$4.8m

A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

Chimeric Therapeutics

Market Cap: AU$7.4m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Genflow Biosciences

Market Cap: UK£3.5m

Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.

Ecofibre

Market Cap: AU$7.3m

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

Xenetic Biosciences

Market Cap: US$4.7m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Epsilon Healthcare

Market Cap: AU$7.2m

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

dorsaVi

Market Cap: AU$7.3m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

Adial Pharmaceuticals

Market Cap: US$4.7m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

Valeo Pharma

Market Cap: US$4.6m

A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.

Belluscura

Market Cap: UK£3.4m

Develops and commercialize oxygen related medical device products in the United States.

Burzynski Research Institute

Market Cap: US$4.6m

Engages in the research and development of antineoplaston drugs for the treatment of various cancers.

American Films

Market Cap: US$4.6m

Does not have significant operations.

SenesTech

Market Cap: US$4.6m

Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

PD-Rx Pharmaceuticals

Market Cap: US$4.5m

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.

Bakhu Holdings

Market Cap: US$4.5m

Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.

Invex Therapeutics

Market Cap: AU$7.0m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

Virax Biolabs Group

Market Cap: US$4.5m

A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.

Delivra Health Brands

Market Cap: CA$6.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Regional Health Properties

Market Cap: US$4.5m

Operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living.

Caduceus Software Systems

Market Cap: US$4.5m

Through its subsidiary, McLovin's Pet Food, Inc., operates as a pet food and pet care company.

CanadaBis Capital

Market Cap: CA$6.2m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

T2 Biosystems

Market Cap: US$4.5m

An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.

Zero Candida Technologies

Market Cap: CA$6.2m

A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.

WEED

Market Cap: US$4.5m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

Autonomix Medical

Market Cap: US$4.4m

A development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

Azitra

Market Cap: US$4.4m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Aptose Biosciences

Market Cap: CA$6.1m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

Fuse Medical

Market Cap: US$4.4m

Manufactures and distributes medical devices in the United States.

Mitesco

Market Cap: US$4.4m

Engages in providing cloud computing, application hosting, and other data center related applications.

Centogene

Market Cap: US$4.4m

Provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific.

Visionflex Group

Market Cap: AU$6.7m

Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.